{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:39:13Z","timestamp":1786718353776,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Afr Med"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/aam.aam_35_17","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T01:24:18Z","timestamp":1508117058000},"page":"164","source":"Crossref","is-referenced-by-count":2,"title":["Clinicians-related determinants of anticoagulation therapy and prophylaxis in Nigeria"],"prefix":"10.4103","volume":"16","author":[{"given":"Theresa","family":"Nwagha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Anakwue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OgbaJ","family":"Ukpabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndudim","family":"Obeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Onwubuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwa","family":"Onwuchekwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Azubuike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Okoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1596-3519.216713-1","first-page":"71","volume-title":"Estimation and comparison of intra operative blood loss in patients with and without venous thromboembolism prophylaxis","author":"Ahsin","year":"2014","journal-title":"Pak Armed Forces Med J"},{"key":"key-10.4103\/1596-3519.216713-2","first-page":"286","volume-title":"Prevention of venous thromboembolism: Consensus, controversies, and challenges","author":"Selby","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key-10.4103\/1596-3519.216713-3","first-page":"381S","volume-title":"Prevention of venous thromboembolism: American College of Chest Physicians evidence-Based clinical practice guidelines (8th edition)","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"key-10.4103\/1596-3519.216713-4","doi-asserted-by":"crossref","unstructured":"Fitz Maurice DA, Murray E. Thrombophylaxis for adults in hospital. BMJ 1997;1017-8.","DOI":"10.1136\/bmj.39210.496505.BE"},{"key":"key-10.4103\/1596-3519.216713-5","first-page":"387","volume-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study","author":"Cohen","year":"2008","journal-title":"Lancet"},{"key":"key-10.4103\/1596-3519.216713-6","first-page":"349","volume-title":"Canadian atrial Fibrillation Anticoagulation (CAFA) study","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/1596-3519.216713-7","first-page":"1255","volume-title":"EAFT (European Atrial Fibrillation Trial) Study Group","author":"Secondary","year":"1993","journal-title":"Lancet"},{"key":"key-10.4103\/1596-3519.216713-8","first-page":"1406","volume-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation.Veterans affairs stroke prevention in nonrheumatic atrial fibrillation investigators","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1596-3519.216713-9","first-page":"527","volume-title":"final results","author":"Stroke","year":"1991","journal-title":"Circulation"},{"key":"key-10.4103\/1596-3519.216713-10","first-page":"2719","volume-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation.developed with the special contribution of the european heart rhythm association","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"key-10.4103\/1596-3519.216713-11","first-page":"el","volume-title":"2014 AHA\/ACC\/HRS Guidelines for the management of patients with atrial fibrillation: A report of the ACC\/AHA TaskForce on Practice Guidelines and the HRS","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/1596-3519.216713-12","first-page":"41","volume-title":"Why do patients with atrial fibrillation not receive warfarin?","author":"Bungard","year":"2000","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/1596-3519.216713-13","first-page":"e278s","volume-title":"Prevention of VTE in orthopaedic surgery patients; antithrombotic therapy and prevention of thrombosis 9th ed.; American College of Chest Physicians evidence-based clinical practice guidelines","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"key-10.4103\/1596-3519.216713-14","unstructured":"Kakkar AK. Prevention of venous thromboembolism in general surgery. In: Colman RW, Cloves AW, George JN, Marder VJ, Goldhaber SZ, ed. Haemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. Philadelphia: Lippincott, William and Wilkins; 2006. p. 1361-7"},{"key":"key-10.4103\/1596-3519.216713-15","first-page":"e195S","volume-title":"Prevention of VTE in nonsurgical patients: Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines","author":"Kahn","year":"2012","journal-title":"Chest"},{"key":"key-10.4103\/1596-3519.216713-16","first-page":"59","volume-title":"Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the united states","author":"Caprini","year":"2003","journal-title":"Value Health"},{"key":"key-10.4103\/1596-3519.216713-17","first-page":"286","volume-title":"Utilisation of oral anticoagulation in a teaching hospital in Nigeria","author":"Anakwue","year":"2014","journal-title":"Ann Med Health Sci Res","ISSN":"https:\/\/id.crossref.org\/issn\/2141-9248","issn-type":"print"},{"key":"key-10.4103\/1596-3519.216713-18","first-page":"58","volume-title":"the competitiveness of Saudi pharmaceutical industry using porter 5 forces analysis","author":"Mba","year":"2016","journal-title":"Eur J Bus Manage"},{"key":"key-10.4103\/1596-3519.216713-19","first-page":"24","volume-title":"Emergency-room doctors' knowledge about oral anticoagulants and its management","author":"Periotto","year":"2010","journal-title":"J Vasc Bras"},{"key":"key-10.4103\/1596-3519.216713-20","first-page":"42","volume-title":"Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events","author":"Doroodchi","year":"2008","journal-title":"BMC Fam Pract"},{"key":"key-10.4103\/1596-3519.216713-21","first-page":"499","volume-title":"National study of physician awareness and adherence to cardiovascular disease prevention guidelines","author":"Mosca","year":"2005","journal-title":"Circulation"},{"key":"key-10.4103\/1596-3519.216713-22","first-page":"1416","volume-title":"The role of NOACs in atrial fibrillation management: A qualitative study","author":"Kirley","year":"2016","journal-title":"J Atr Fibrillation"},{"key":"key-10.4103\/1596-3519.216713-23","first-page":"1","volume-title":"Will NOACs become the new standard of care in anticoagulation therapy?","author":"Oktay","year":"2015","journal-title":"Int J Cardiovasc Acad"},{"key":"key-10.4103\/1596-3519.216713-24","first-page":"640","volume-title":"Guideline on aspects of cancer-related venous thrombosis","author":"Watson","year":"2015","journal-title":"Br J Haematol"},{"key":"key-10.4103\/1596-3519.216713-25","first-page":"19","volume-title":"Challenges of anticoagulation in atrial fibrillation: An African perspective","author":"Okeahialam","year":"2005","journal-title":"Trop Card"},{"key":"key-10.4103\/1596-3519.216713-26","first-page":"315","volume-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"key-10.4103\/1596-3519.216713-27","first-page":"311","volume-title":"Guidelines on oral anticoagulation with warfarin-Fourth edition","author":"Keeling","year":"2011","journal-title":"Br J Haematol"},{"key":"key-10.4103\/1596-3519.216713-28","first-page":"695","volume-title":"Understanding the RECORDS 3 trial and its impact on anticiagulation practice in resource poor countries","author":"Nwagha","year":"2016","journal-title":"Niger J Clin Pract","ISSN":"https:\/\/id.crossref.org\/issn\/1119-3077","issn-type":"print"},{"key":"key-10.4103\/1596-3519.216713-29","first-page":"1557","volume-title":"Bleeding complications in oral anticoagulant therapy.An analysis of risk factors","author":"van","year":"1993","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/1596-3519.216713-30","first-page":"e009397","volume-title":"Implementing guidelines to routinely prevent chronic vascular disease in primary care: The preventive evidence into practice cluster randomised controlled trial","author":"Harris","year":"2015","journal-title":"BMJ Open"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:34:13Z","timestamp":1786714453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_35_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["216713"],"URL":"https:\/\/doi.org\/10.4103\/aam.aam_35_17","relation":{},"ISSN":["1596-3519"],"issn-type":[{"value":"1596-3519","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}